AZT, ddI, and ddC combinations at FDA advisory hearing. Food and Drug Administration.
James
J S
JS
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000998:Antiviral Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D016049:Didanosine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D016047:Zalcitabine / Q000008:administration & dosage; D015215:Zidovudine / Q000008:administration & dosage
D000998:Antiviral Agents; D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine